16406-00-1Relevant articles and documents
SUBSTITUTED BENZIMIDAZOLES AS POTASSIUM CHANNEL INHIBITORS
-
Page/Page column 58; 60; 61, (2019/03/05)
The present invention relates to a compound of the general formula (I). The compounds of formula I are useful for treatment of a cardiac disease, disorder or condition in a mammal.
Cyclic bis-benzimidazole ligands and metal complexes thereof
-
, (2008/06/13)
Cyclic bis benzimidazole ligands of the following formula are formed by contacting a (2-aminophenyl)-benzimidazole-4-carboxaldehyde ethylene acetal or a (2-nitrophenyl)-benzimidazole-4-benzaldehyde with an acid optionally in the presence of a metal or a metal salt. wherein R1and R2may be the same or different and are selected from H, an alkyl having 1 to 10 carbon atoms, a benzyl group, a substituted 2-ethylphenyl group, a carbonyl group, a phenyl substituent, a tosyl group, and an alkylsulfonate group; R3and R4may be the same or different and are selected from H, methyl, and ethyl; and R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17, and R18may be the same or different and are selected from H, alkyl having 1 to 10 carbon atoms, fluoride, chloride, bromide, iodide, nitro, amino, a carboxylate, an ester, and a phenyl group.
Synthesis of a new type of "bent" heterocyclic benzimidazolo-pyridazinones
Jonas, R,Pruecher, H,Wurziger, H
, p. 141 - 148 (2007/10/02)
The synthesis of some new heterocyclic benzimidazolo-pyridazinines starting from 2,1,3-benzothiadiazole-4-carboxaldehyde 2 is described.Biological evaluation of all new compounds proved them to be inhibitors of phosphodiesterase III with no marked positiv